but the graft was worth it. The venue now boasts versatility and splendour ready to accommodate a slew of events from ...

Results from the GLORIOUS trial indicated that exenatide did not decrease mortality or severe organ injury among patients who ...

Emerging research highlights the cardiovascular benefits of popular anti-obesity medications, such as GLP-1-based therapies.

In two studies the acellular tissue engineered vessel (ATEV) provided benefits in terms of patency, limb salvage, and infection resistance ...

(JAMA Network Open) Among patients undergoing isolated coronary artery bypass grafting, partial cardiac denervation helped ...

A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog ...

Humacyte (HUMA) Presents Preclinical Results of Small-Diameter ATEV(TM) for Coronary Artery Bypass Grafting at American Heart Association’s Scientific Sessions 2024 – sdATEVs maintained sustained ...

enabling them to approach heart transplant in optimal physical condition when a human graft becomes available. Out of these 30 transplants carried out in 7 different countries (including 16 in France ...

This randomized clinical trial found that partial cardiac denervation was an effective procedure to reduce the occurrence of postoperative atrial fibrillation (POAF) after isolated coronary artery ...

Patients who receive pulmonary artery catheters (PACs) after cardiac surgery have significantly reduced risk for 1-year mortality.

A statement from Croatia’s Office for the Suppression of Corruption and Organised Crime, or USKOK, did not specify who was arrested but Croatian media reported it was Health Minister Vili Beros. The ...